 |
|
Clinical and Prognostic Values of DNMT3B Expression in Hepatocellular Carcinoma
Jongwan Kim, Jae-Hee Park, Jae-Ho Lee
Keimyung Med J. 2022;41(1):13-16. Published online 2022 May 30 DOI: https://doi.org/10.46308/kmj.2022.00045
|
|
Citations to this article as recorded by
 Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers
Mincheol Chae, Jae-Ho Lee, Jong Ho Park, Dong Yoon Keum, Hanna Jung, Youngok Lee, Deok Heon Lee
OncoTargets and Therapy.2024; Volume 17: 463. CrossRef A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma
Wei He, Zixiang Cong, Chengtao Niu, Fajuan Cheng, Tinghai Yi, Zhongshun Yao, Yiming Zhang, Xue Jiang, Xintong Sun, Zhihong Niu, Qiang Fu
Scientific Reports.2024;[Epub] CrossRef Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata
An-Na Bae, Jongwan Kim, Jong-Ho Park, Jae-Ho Lee, Euncheol Choi
Medicina.2023; 59(10): 1782. CrossRef Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
Chunjie Huang, Paniz Azizi, Masoud Vazirzadeh, Seyed Mohsen Aghaei-Zarch, Fatemehsadat Aghaei-Zarch, Jalaledin Ghanavi, Poopak Farnia
Journal of Translational Medicine.2023;[Epub] CrossRef
|